In the study of different polycrystalline structures, within a drug compound, one polymorph is distinguished from another by a unique powder diffraction pattern associated with that specific crystal structure.
Parikshit Raha on LinkedIn: Rigaku Launches the ZSX Primus III NEXT – High-speed Analysis in an…
NEX CG II Rigaku Global Website
XRTmicron Rigaku Global Website
Quantitative analysis of pharmaceutical polymorphic forms via the DD Method
XtaLAB Synergy-ED Rigaku Global Website
Pharmaceuticals Rigaku Global Website
Rigaku Timeline Rigaku Global Website
Summer 2008, Volume 24, No. 1
Detection of low-level polymorphic impurities in pharmaceuticals
Advanced and New Materials
Micro-Z CL Rigaku Global Website
X-ray thin-film measurement techniques V. X-ray reflectivity measurement
Improvements for high-pressure cell experiments using the latest single crystal laboratory systems
Quantitative analysis of pharmaceutical polymorphic forms via the DD Method
SmartLab Intelligent XRD for Battery